CNTB
Connect Biopharma Holdings Ltd
0.927$
-5.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 4.0% | 2.0% | – | 26.3% | – | – | – | – | – | – | – | |
| – | – | -4.0% | 100.0% | – | 100.0% | – | 100.0% | – | 100.0% | – | 100.0% | – | |
| – | – | 218.6% | 22.2% | 739.0% | 893.4% | – | 18,277.1% | 69,437.5% | 70,512.5% | 8,893.5% | 554.1% | 1,711.1% | |
| – | – | 66.0% | 21.2% | 496.8% | 584.7% | – | 9,789.6% | 41,143.8% | 26,525.0% | 2,808.3% | 139.6% | 626.9% | |
| – | – | 306.4% | 43.4% | 1,235.8% | 1,478.1% | – | 28,066.7% | 110,581.3% | 97,037.5% | 11,701.8% | 1,367.0% | 2,968.2% | |
| – | – | -306.4% | 56.6% | -1,135.8% | -1,378.1% | – | -27,966.7% | -110,481.3% | -97,037.5% | -11,601.8% | -1,267.0% | -2,868.7% | |
| – | – | 0.1% | 0.1% | – | 2.9% | – | – | – | – | – | – | – | |
| – | – | -261.9% | 61.7% | -1,051.6% | -1,260.7% | – | -26,758.3% | -107,118.8% | -94,262.5% | -11,449.7% | -1,245.3% | -2,809.0% | |
| – | – | 0.5% | 0.1% | – | 15.2% | – | 114.6% | – | 168.8% | – | 3.7% | – | |
| – | – | -262.3% | 61.6% | -1,056.3% | -1,275.9% | – | -26,872.9% | -107,500.0% | -94,431.3% | -11,478.1% | -1,249.0% | -2,816.7% | |
| – | – | -293.1% | 62.4% | – | -1,238.1% | – | -26,402.1% | -109,362.5% | -93,131.3% | -11,504.7% | -1,255.9% | -2,827.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.